{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:42:57Z","timestamp":1740145377964,"version":"3.37.3"},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":1564,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 DA 15999-01"],"award-info":[{"award-number":["R01 DA 15999-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001027","name":"Australian Government Department of Health and Aging","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001027","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","journals.elsevierhealth.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.jmoldx.2015.05.003","type":"journal-article","created":{"date-parts":[[2015,7,5]],"date-time":"2015-07-05T12:22:11Z","timestamp":1436098931000},"page":"583-589","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Interferon \u03bb 3 and 4 Genotyping Using High-Resolution Melt Curve Analysis Suitable for Multiple Clinical Sample Types"],"prefix":"10.1016","volume":"17","author":[{"given":"Fran\u00e7ois M.J.","family":"Lamoury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan","family":"Jacka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behzad","family":"Hajarizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Grebely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail V.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory J.","family":"Dore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya L.","family":"Applegate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2015.05.003_bib1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","article-title":"Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies","volume":"13","author":"Micallef","year":"2006","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jmoldx.2015.05.003_bib2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/hep.26639","article-title":"The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection","volume":"59","author":"Grebely","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jmoldx.2015.05.003_bib3","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jmoldx.2015.05.003_bib4","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2009.12.056","article-title":"Genetic variation in, IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study","volume":"138","author":"Rauch","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jmoldx.2015.05.003_bib5","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","article-title":"IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy","volume":"41","author":"Suppiah","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.jmoldx.2015.05.003_bib6","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.2521","article-title":"A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus","volume":"45","author":"Prokunina-Olsson","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.jmoldx.2015.05.003_bib7","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1038\/emboj.2013.232","article-title":"Interferon lambda 4 signals via the IFNlambda receptor to regulate antiviral activity against HCV and coronaviruses","volume":"32","author":"Hamming","year":"2013","journal-title":"EMBO J"},{"key":"10.1016\/j.jmoldx.2015.05.003_bib8","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1038\/ncomms6699","article-title":"Reduced IFNlambda4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes","volume":"5","author":"Terczynska-Dyla","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.jmoldx.2015.05.003_bib9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/hep.25792","article-title":"Will IL28B polymorphism remain relevant in the era of direct-acting antiviral agents for hepatitis C virus?","volume":"56","author":"Thompson","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jmoldx.2015.05.003_bib10","doi-asserted-by":"crossref","first-page":"6422","DOI":"10.1038\/ncomms7422","article-title":"Interferon-lambda rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease","volume":"6","author":"Eslam","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jmoldx.2015.05.003_bib11","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1373\/49.6.853","article-title":"High-resolution genotyping by amplicon melting analysis using LCGreen","volume":"49","author":"Wittwer","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.jmoldx.2015.05.003_bib12","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1373\/clinchem.2004.032136","article-title":"Genotyping of single-nucleotide polymorphisms by high-resolution melting of small amplicons","volume":"50","author":"Liew","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.jmoldx.2015.05.003_bib13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/j.gastro.2009.09.019","article-title":"Effective treatment of injecting drug users with recently acquired hepatitis C virus infection","volume":"138","author":"Dore","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jmoldx.2015.05.003_bib14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2147\/HMER.S41127","article-title":"Pharmacogenetics of hepatitis C: transition from interferon-based therapies to direct-acting antiviral agents","volume":"6","author":"Kamal","year":"2014","journal-title":"Hepat Med"},{"key":"10.1016\/j.jmoldx.2015.05.003_bib15","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1089\/jir.2013.0136","article-title":"IFN-lambda4: the paradoxical new member of the interferon lambda family","volume":"34","author":"O'Brien","year":"2014","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.jmoldx.2015.05.003_bib16","doi-asserted-by":"crossref","first-page":"O936","DOI":"10.1111\/1469-0691.12637","article-title":"High-resolution melting assay for genotyping of IFNL4-associated dinucleotide variant rs368234815","volume":"20","author":"Galmozzi","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jmoldx.2015.05.003_bib17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/jgh.12424","article-title":"Distribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: analysis from the PREDICT and CHARIOT studies","volume":"29","author":"Roberts","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jmoldx.2015.05.003_bib18","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/hep.26675","article-title":"Disease progression during advanced fibrosis: IL28B genotype or HCV RNA levels?","volume":"59","author":"Grebely","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jmoldx.2015.05.003_bib19","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1097\/01.aids.0000433234.78807.54","article-title":"Variation in IFNL4 genotype and response to interferon-based therapy of hepatitis C in HIV-positive patients with acute and chronic hepatitis C","volume":"27","author":"Kramer","year":"2013","journal-title":"AIDS"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157815001178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157815001178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T07:44:46Z","timestamp":1576223086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157815001178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S1525157815001178"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2015.05.003","relation":{},"ISSN":["1525-1578"],"issn-type":[{"type":"print","value":"1525-1578"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon \u03bb 3 and 4 Genotyping Using High-Resolution Melt Curve Analysis Suitable for Multiple Clinical Sample Types","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2015.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}